An "exacerbate-reverse" strategy in yeast identifies histone deacetylase inhibition as a correction for cholesterol and sphingolipid transport defects in human Niemann-Pick type C disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples